Key result
Right heart failure and aortic insufficiency hemodynamic-related events at 6 months post-dLVAD implantation independently increased the risk of HF hospitalization or cardiovascular death (adjusted HR 2.69 and 4.21).
Why the study?
Durable LVAD physiology predisposes to right heart failure and aortic insufficiency (hemodynamic-related events), motivating validation of the recently proposed dLVAD Hemodynamic Classification System.
Does the Hemodynamic Classification System for hemodynamic-related events (RHF and AI) predict heart failure hospitalization or cardiovascular death in patients with durable LVADs?
Cohort (n=183)
No
Does the Hemodynamic Classification System for hemodynamic-related events (RHF and AI) predict heart failure hospitalization or cardiovascular death in patients with durable LVADs?
The Hemodynamic Classification System is a valid and robust prognostic tool to identify and stratify right heart failure and aortic insufficiency events in patients with durable left ventricular assist devices, directly correlating with future risks of HF hospitalization and cardiovascular death.
Answers are grounded in this paper and cite their sources.
Post-dLVAD right heart failure and aortic insufficiency events were associated with higher composite risk; hypothesis-generating for the hemodynamic classification system's utility.
Background Durable left ventricular assist device (dLVAD) physiology predisposes to right heart failure (RHF) and aortic insufficiency (AI), recently labeled hemodynamic‐related events (HDREs). We sought to validate the recently proposed dLVAD Hemodynamic Classification System for HDREs. Methods RHF and AI HDREs were adjudicated, staged, and phenotyped on the basis of the Hemodynamic Classification System assessed at 6 months after dLVAD implantation. The primary outcome was a composite of HF hospitalization or cardiovascular death between 6 and 24 months after dLVAD implantation. Results Among 183 qualifying consecutive patients with 6‐month assessments, RHF HDRE was adjudicated in all cases and AI HDRE in 161 (88.0%). Overall, 53 (29.0%) patients developed an RHF HDRE and 26 (16.0%) an AI HDRE (phenotypes: 39 isolated RHF, 15 isolated AI, 11 combined RHF–AI, 3 not adjudicated). At pre‐dLVAD assessment, age and pulmonary artery pulsatility index were independently associated with RHF HDRE and pre‐dLVAD AI and systolic pulmonary artery pressure with AI HDRE. RHF HDRE (adjusted hazard ratio [HR], 2.69 [95% CI, 1.14–6.34]; P =0.024), AI HDRE (adjusted HR, 4.21 [95% CI, 1.70–10.40]; P =0.002), and HDRE phenotypes (isolated RHF/AI HDRE versus no HDRE: adjusted HR, 2.80 [95% CI, 1.03–7.62]; P =0.044; combined RHF/AI HDRE versus no HDRE: adjusted HR, 4.53 [95% CI, 1.33–15.35]; P =0.015) were associated with the primary outcome. A graded increase in primary outcome was observed with increasing RHF and AI stages. Conclusions We validated the dLVAD Hemodynamic Classification System for HDREs as a valuable tool to identify pathophysiological and clinical clusters of patients, linking it with significant prognostic implications. Its adoption may pave the way for targeted strategies aimed at mitigating HDREs and enhancing the long‐term success of dLVAD support.
No takes yet. Share an insight, caveat, or question.
Gallone et al. (2025) conducted a cohort in Advanced heart failure supported with a durable left ventricular assist device (dLVAD) (n=183). Right heart failure (RHF) or aortic insufficiency (AI) hemodynamic-related events (HDREs) vs. No HDRE was evaluated on Composite of HF hospitalization or cardiovascular death between 6 and 24 months after dLVAD implantation (HR 2.69, 95% CI 1.14-6.34, p=0.024). Right heart failure and aortic insufficiency hemodynamic-related events at 6 months post-dLVAD implantation independently increased the risk of HF hospitalization or cardiovascular death (adjusted HR 2.69 and 4.21).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: